Browse All

Current Filters

CLEAR FILTER x

TITLE

Prevalence and Characteristics of Women with Menstrual Migraine in the 2021 United States National Health & Wellness Survey

Treatment with Zavegepant Offers Improvements in Pain Severity Over 48-hours When Compared with Placebo—Post Hoc Results from a Randomized Placebo-controlled Trial (BHV3500-301)